Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Seeking Alpha

Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish

Pfizer reported strong earnings and earnings guidance. Large, unusual call option activity today, as noted in a Barchart report, indicates investors are bullish.

Barchart

1 High-Yield Dividend Stock That’s Up 148% Over the Past Year

Millicom International Cellular (TIGO) is up 148% over the past 52 weeks. TIGO maintains a 100% “Buy” technical opinion from Barchart. TIGO's fundamentals are robust with strong revenue and earnings growth estimates. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings. Today’s Featured Stock Valued at $11.52 billion, Millicom...

Barchart

10 Worst-Performing Stocks of 2025

According to StatMuse, Reuters and Seeking Alpha, these are the 10 worst-performing S&P 500 stocks of 2025.

GOBankingRates

From analysis to the latest developments in health,
read the most diverse news in one place.

Unusual Call Options Volume in GameStop Corp. Stock - Should Investors Buy GME Stock?

GameStop Corp reported excellent results yesterday for its fiscal Q3 ended Nov. 1. Today, there is a huge, unusual call options trading in GME. GME stock is well off its recent highs. Should investors buy GME stock?

Barchart

Fannie Freddie IPO Could Make You Rich; Burry Sees Up to 100 % Gain

Michael Burry predicts Fannie Mae and Freddie Mac shares could double within two years of relisting. Here's what the potential IPO means for ordinary investors eyeing a windfall.

International Business Times UK

This Shipping Stock Has Set 15 New Highs This Month

Costamare (CMRE) has strong technical momentum and just set a new 52-week high. Shares have a 100% technical “Buy” opinion from Barchart. CMRE stock is up nearly 30% in just the last month. Analyst sentiment is mixed, but Morningstar sees CMRE as 19% undervalued and Seeking Alpha rates it a...

Barchart

This Stock Is Up 704% in 2025 But Has No Products to Its Name

Relmada Therapeutics (RLMD) is a clinical-stage pharma company with no commercialized products and a $141 million market cap. RLMD has shown strong technical momentum, gaining 440% since August. Shares have a 100% “Buy” technical opinion from Barchart. Despite technical strength, RLMD lacks revenue, faces pipeline setbacks, and is rated “Hold”...

Barchart

Read news from The Economist, FT, and more,
with one subscription

This Canadian Dividend Stock Just Hit New All-Time Highs

Canadian Imperial Bank of Commerce (CM) just hit an all-time high and has strong technical momentum. The stock maintains a 100% “Buy” Barchart opinion. Shares are up 32.01% over the past year and more than 34% in the year to date. Despite some valuation concerns, most analysts rate CM as...

Barchart

This ‘Strong Buy’ Financial Stock Can Help You Unlock Profits in Peru

Intercorp Financial Services (IFS) is trading at a 5-year high and has strong technical momentum. Shares are up 63% in the past 52 weeks and nearly 50% in the year to date. IFS has a 100% “Buy” opinion from Barchart. Fundamentals remain solid for IFS, with projected revenue and earnings...

Barchart

Micron Stock Keeps Hitting New Record Highs

Micron Technology (MU) is trading at new all-time highs and has strong technical momentum. MU has a 100% “Buy” opinion from Barchart. The stock is up 125% in the past year and over 180% in the year to date. Analyst sentiment is overwhelmingly bullish, with multiple “Strong Buy” ratings, although...

Barchart

This Data Center Stock Is Up 1,300% in Just 3 Years

Vertiv (VRT) has exceptional price momentum and is hitting new all-time highs. VRT maintains a 100% “Buy” opinion from Barchart. Shares have surged 75% over the past year and analysts project robust earnings and revenue growth ahead. Vertiv’s growth is fueled by its strategic role in the AI-driven data center...

Barchart

4 Tesla Stock Mistakes That Cost Investors Thousands

Tesla's stock is positive for 2025 despite major setbacks it faced earlier this year. Learn the four costly investor mistakes to avoid before jumping in.

GOBankingRates

This ‘Strong Buy’ Stock Is a Classic – and It Pays a Dividend Too

Ralph Lauren (RL) boasts strong technical momentum and is trading at new all-time highs. Shares have a 100% “Buy” opinion from Barchart and are up 66% over the past year. RL fundamentals are solid, as analysts project revenue and earnings growth. However, there is reason for caution due to Ralph...

Barchart

This Red-Hot Biopharma Stock Could Fizzle Out Soon

Roivant Sciences (ROIV) shows strong technical momentum and is trading at new all-time highs. Shares are up 52% over the past year and 20% in the last month. ROIV has a 100% “Buy” opinion from Barchart and a Trend Seeker “Buy” signal. Despite the price gains, Roivant lacks consistent revenue...

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Alphabet Stock Off Its Peak - Is It Undervalued? It Could Be If FCF Stays Strong

Alphabet stock has declined from its recent peak. But is there any significant upside from here? It's possible, especially if its free cash flow (FCF) remains strong. It could be up to 25% too cheap.

Barchart

This ‘Darling’ Pharma Stock Is Hitting New Highs

Rigel Pharmaceuticals (RIGL) is showing exceptional momentum, setting new 52-week highs on Aug. 22. Shares are up nearly 243% over the past year. The stock is trading above key moving averages and is supported by several “Strong Buy” analyst ratings. Fundamentals show impressive projected earnings growth this year, but both...

Barchart

This Penny Stock Has Wall Street's Attention and Is Up Nearly 600%

ImmunoPrecise Antibodies (IPA) shows strong technical momentum, hitting new 52-week highs on Aug. 21. The stock maintains a 100% “Buy” opinion from Barchart. Shares are up an impressive 565% in 2025. Despite bullish analyst sentiment, IPA is volatile and speculative. Today’s Featured Stock Valued at only $121 million, ImmunoPrecise Antibodies...

Barchart

Pfizer Raises Its Guidance and Analysts Up Their Targets - PFE Stock Looks Cheap

Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year. That's too cheap. Shorting puts works here.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Fiserv Stock Gets Pummeled After Earnings - Looks Cheap Here

Fiserv stock is down over 13% in the last week since its Q2 earnings were released. But was it really all that bad? After all, it generated strong earnings and free cash flow. FI stock looks cheap here.

Barchart

MSCI, the Index Company, Forecasts Strong Free Cash Flow, Looks Undervalued

MSCI, Inc., the stock index company, produced robust Q2 earnings and forecasted strong free cash flow margins. MSCI stock looks deeply undervalued here, and shorting OTM put options for income is a good play.

Barchart

Delta Air Lines Shows Unusual Call Options Ahead of Earnings - Investors are Bullish on DAL Stock

Barchart's Unusual Stock Options Activity Report shows Delta Air Lines (DAL) call options traded today. That is a bullish signal from investors ahead of its Q2 earnings release tomorrow, before the market opens.

Barchart

Constellation Brands Stock is Down But Produced Good Earnings - Is STZ a Buy Here?

Constellation Brands, which sells Corona and Modelo beers, generated lower sales but maintained its free cash flow guidance. STZ stock is down from its highs. Based on its historical averages, it appears to be a bargain.

Barchart

Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook

Large unusual trading volume in Pfizer put options that expire 30 days from now signals investors' bullish outlook on PFE stock. It trades for just over 8 times earnings, well below its 10-year historical average P/E ratio.

Barchart

Nvidia's Free Cash Flow and FCF Margins Skyrocket - NVDA Stock Looks Cheap

Nvidia Inc. reported strong revenue, free cash flow (FCF), and FCF margins. This implies a much higher valuation for NVDA stock - over $191 per share. Short-put plays are also attractive here, and they have high yields.

Barchart

GameStop Stock Could Surge From Here - All Eyes are On Its Results

GameStop Corp. is now solidly free cash flow positive, as its FCF margin last quarter was 12.4% of sales. Its upcoming June 9 results will show how much Bitcoin it may have bought. These two factors could push GME even higher.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.